For U.S. Residents Only
Technical Update: Challenge Study Shows Vira Shield 6+VL5 HB
Provided 12-Month Duration of Immunity Against
Technical Update: Study demonstrates that Vira Shield® 6 provides cell-mediated immune response
Sign up for eAlerts
View More Videos
IBR Dialogues – Resource Center
VIRA SHIELD is a registered trademark of Novartis AG.